[1]
W. Azariani, A. D. Ananto, and S. A. I. Maulidya, “In Silico Assessment of GSK-3? Inhibition Activity by Secondary Metabolites of Centella asiatica in the Development of Alzheimer’s Therapy”, J. Trop. Pharm. Chem., vol. 9, no. 2, pp. 64–70, Dec. 2025.